CLINICAL_TRIALS
trial_result
· 2020-06-16
Clinical Trial Update: Study of Ataluren (PTC124) in Hemophilia A and B [Phase 2]
Summary
Phase 2 trial of ataluren (PTC124) in Hemophilia A and B was terminated; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PTC Therapeutics | Conditions: Hemophilia A, Hemophilia B | Phase 2 | Status: TERMINATED | Results posted: 2020-06-16